Dynatrace holder may sell 50K shares, $2.9M

Dynatrace, Inc. (DT) is the issuer for a proposed resale of 50,000 shares of common stock under Rule 144 for the account of Bernd Greifeneder, with UBS Financial Services Inc. acting as attorney-in-fact and broker.

Rhea-AI Filing Summary

Dynatrace, Inc. (DT) is the issuer for a proposed resale of 50,000 shares of common stock under Rule 144 for the account of Bernd Greifeneder, with UBS Financial Services Inc. acting as attorney-in-fact and broker. The shares have an indicated aggregate value of $2,860,500 and are associated with trading on the NYSE as of September 18, 2026.

Key Figures

Shares of common stock subject to Rule 144 notice: 50,000 shares Aggregate value of shares: $2,860,500 Trading venue: NYSE +3 more

6 metrics

Shares of common stock subject to Rule 144 notice 50,000 shares Common stock of Dynatrace, Inc. proposed for sale for the account of Bernd Greifeneder

Aggregate value of shares $2,860,500 Aggregate value listed for the 50,000 Dynatrace common shares covered by the notice

Trading venue NYSE Exchange associated with the Dynatrace common stock in the securities information section

Referenced date in securities information September 18, 2026 Date listed alongside the Dynatrace common stock and NYSE

Earlier referenced date March 11, 2026 Appears in the remarks and signature area of the notice

Historical date related to common stock entry November 30, 2015 Date listed twice in the securities to be sold section for the common stock

Key Terms

Rule 144, attorney-in-fact, NYSE, Common, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

attorney-in-fact regulatory

"Signature | /s/ UBS Financial Services Inc, as attorney-in-fact for Bernd"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

NYSE market

"| 289002128 | 09/18/2026 | NYSE"

A large, regulated marketplace where stocks and other securities are listed and traded, acting like a global auction house that matches buyers and sellers and helps determine share prices. It matters to investors because listing and trading there provide liquidity, price discovery, and regulatory oversight—making it easier to buy or sell holdings and giving companies a visible platform that can affect credibility and access to capital.

Common financial

"Common | UBS Financial Services Inc. 11 Madison Avenue"

Federal Criminal Violations regulatory

"Intentional misstatements or omission of facts constitute Federal Criminal Violations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for Dynatrace, Inc. (DT)?

The notice states that 50,000 shares of Dynatrace common stock may be sold under Rule 144 for the account of Bernd Greifeneder. This reflects a potential secondary sale by an existing holder, not an issuance of new shares by Dynatrace.

How many Dynatrace (DT) shares are covered by this Form 144?

The filing covers up to 50,000 shares of Dynatrace common stock proposed to be sold for the account of Bernd Greifeneder. These shares are listed in the securities information section of the notice.

What is the approximate value of the Dynatrace (DT) shares in this Form 144?

The securities information section lists an aggregate value of $2,860,500 for the 50,000 shares of Dynatrace common stock that may be sold under Rule 144.

On which exchange are the Dynatrace (DT) shares in this Form 144 traded?

The notice associates the Dynatrace common stock covered by this Form 144 with trading on the NYSE, as indicated in the securities information section.

Who is the beneficial holder in this Dynatrace (DT) Form 144 filing?

The shares are to be sold for the account of Bernd Greifeneder. UBS Financial Services Inc. signs the notice as attorney-in-fact for Bernd Greifeneder and is named in connection with the common stock.

What key dates are mentioned in the Dynatrace (DT) Form 144?

The filing references September 18, 2026 in the securities information section and March 11, 2026 in the remarks and signature area. It also notes November 30, 2015 in connection with the listed common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 04:07 PM Accepted by SEC EDGAR 09/18/2026 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783507
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Dynatrace, Inc.
SEC File Number	001-39010
Address of Issuer	280 CONGRESS STREET 11TH FLOOR BOSTON MASSACHUSETTS 02210
Phone	781-530-1000
Name of Person for Whose Account the Securities are To Be Sold	Greifeneder Bernd
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	50000	2860500.00	289002128	09/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/30/2015	MIU	Issuer			50000	11/30/2015	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Bernd Greifeneder
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)